Clinical trial
VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent…
NCT00436501 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00436501 |
|---|---|
| Title | VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer |
| Official title | Phase I/II and Pharmacokinetic Study of Docetaxel Plus VEGF Trap (AVE0005, NSC# 724770) in Patients With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Malignant Tumor of Peritoneum, Recurrent Ovarian Epithelial Cancer |
| Intervention type | Biological, Drug, Other |
| Interventions | docetaxel, ziv-aflibercept, laboratory biomarker analysis, pharmacological study |
| Enrollment | 58 |
| Start date | Jan 1, 2007 |
| Primary completion | Mar 1, 2011 |
| Completion | Nov 1, 2012 |
| First posted | Feb 19, 2007 |
| Last update posted | Feb 26, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: